IMMUVERA THERAPEUTICS AS

Operating

Selskapet skal utvikle produkter innenfor 'life science' og utføre konsulent, og forskningsoppdrag på vegne av kunder.

Keywords

engineering servicespowerenergytransportwatersewagedrainageindustrymanufacturingtelecommunicationsbroadcastingpolicy analysisregulationsexpert opinionswitness statementsmechanical engineeringautomotive engineeringchemical engineeringtechnical consulting

Organization

CEO: JS
Jørund Sollid1976
Chairman of the board: MS
Marcus Sahlin Pettersen1978
Years since formation: 6 years; since Dec 5, 2020
Type: Limited company
VAT registered: Yes
Number of employees: 0

Ownership

Number of shares and share classes: 5,391,188; 1 share class
Total number of shareholders: 936; 117 companies, 819 persons
Belongs to group of

Financials

Total operating income 2024: 220,410; NOK
Annual total result 2024: -5,918,424; NOK
Total equity 2024: 15,816,725; NOK

Last update: Dec 12, 2025

Locations

Company address
Gaustadalléen 21 0349 OSLO, Norge
Copied!

Management

Management / administration

Name	Role	Shares
JS Jørund Sollid 1976	Managing Director/CEO	-

Board

Name	Role	Shares
MS Marcus Sahlin Pettersen 1978	Chairman	12.54 % indirectly
PM Peter Mollø-Christensen Knudsen 1962 Resigned	Board Member	1.61 % directly 0.02 % indirectly 1.59 %
KM Kristin Malene Bjerke 1987	Board Member	5.9 % indirectly
CJ Christoffer James Falchenberg 1984 Resigned	Board Member	2.57 % indirectly

Others

Name	Role	Shares
F FIRST ACCOUNTING AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
MS Marcus Sahlin Pettersen 1978	Chairman	12.54 % indirectly
CC Christian Claus Bothmann 1965	-	8.36 % directly < 0.01 % indirectly 8.35 %
KM Kristin Malene Bjerke 1987	Board Member	5.9 % indirectly
LE Lars Espen Strand Nordhus 1988	-	4.68 % indirectly
CJ Christoffer James Falchenberg 1984	Board Member	2.57 % indirectly
MS Monia Sidia 1988	-	2.57 % indirectly
EE Eduard Emilian Grieg 1966	-	2.18 % directly
JB Jørgen Bakke 1951	-	2.17 % directly
NB Nils Berg Johansen 1975	-	2.02 % indirectly
EE Erik Elnes 1963	-	1.85 % indirectly

Last update: Aug 28, 2025

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
A ALV AS	Ordinary shares	2,142,743	39.75 %
E ESTER 4.14 AS	Ordinary shares	450,000	8.35 %
A AMBROSIA AS	Ordinary shares	333,300	6.18 %
G GANDALF AS	Ordinary shares	262,271	4.86 %
EE Eduard Emilian Grieg 1966	Ordinary shares	117,396	2.18 %
JB Jørgen Bakke 1951	Ordinary shares	117,000	2.17 %
LB Lars Buer 1957	Ordinary shares	100,000	1.85 %
M M3 HOLDING AS	Ordinary shares	100,000	1.85 %
O OSLO KAPITALFORVALTNING AS	Ordinary shares	100,000	1.85 %
C C. EMTOR EIENDOM AS	Ordinary shares	60,625	1.12 %
G GAZPACHO AS	Ordinary shares	60,000	1.11 %
CM Christian Mjaaseth 1973	Ordinary shares	59,913	1.11 %
E ECF HOLDING AS	Ordinary shares	50,500	0.94 %
M MOFA INVEST AS	Ordinary shares	50,450	0.94 %
I INGEBJØRG BRATLAND AS	Ordinary shares	50,000	0.93 %
Ø ØKONOMI & BALANSE AS	Ordinary shares	39,874	0.74 %
D DAJEDE AS	Ordinary shares	35,000	0.65 %
T TICA AS	Ordinary shares	33,459	0.62 %
A ARCH HOLDING AS	Ordinary shares	33,300	0.62 %
J JJINVEST AS	Ordinary shares	28,409	0.53 %
G G & T OSLO AS Under liquidation	Ordinary shares	26,200	0.49 %
M MAJOR MAJOR AS	Ordinary shares	25,126	0.47 %
L LÅSBUA AS	Ordinary shares	25,000	0.46 %
IY Ingrid Ylva Sahlin 1953	Ordinary shares	23,493	0.44 %
T TOP SECRET INVEST AS	Ordinary shares	23,000	0.43 %
A ASKAMA AS	Ordinary shares	22,109	0.41 %
A ASE INVEST AS	Ordinary shares	20,955	0.39 %
G GLINDØ HOLDING AS	Ordinary shares	20,371	0.38 %
CA Christopher Aalholm 1969	Ordinary shares	20,000	0.37 %
B BRAK INVEST AS	Ordinary shares	20,000	0.37 %
CM Celine Maria Sedal 1996	Ordinary shares	20,000	0.37 %
E ESS INVESTMENT AS	Ordinary shares	20,000	0.37 %
B BAKS HOLDING AS	Ordinary shares	17,626	0.33 %
JO John Ola Larsen Hjelle 1983	Ordinary shares	15,875	0.29 %
JM Johannes Michael Mollø-Christensen 1965	Ordinary shares	15,000	0.28 %
C CHRISTIANIA FINANS AS	Ordinary shares	15,000	0.28 %
K KARDIOKONSULT AS	Ordinary shares	13,000	0.24 %
ZM Zhanel Mukhamedova 1989	Ordinary shares	10,344	0.19 %
ES Erling Sigurd Johannessen 1953	Ordinary shares	10,000	0.19 %
HS Halvard Sæther 1972	Ordinary shares	10,000	0.19 %
T TM VERDI AS	Ordinary shares	10,000	0.19 %
H HÅBJØRG INVEST AS	Ordinary shares	10,000	0.19 %
S STANDAL AS	Ordinary shares	10,000	0.19 %
SG Sveinung Gundersen Østgård 1985	Ordinary shares	10,000	0.19 %
HJ Håkon Johan Myhre 1966	Ordinary shares	10,000	0.19 %
N NARANMO AS	Ordinary shares	9,988	0.19 %
SK Santifort Koen	Ordinary shares	9,055	0.17 %
DØ Davidsen Øystein 1962	Ordinary shares	9,000	0.17 %
A ANNA RATHE HOLDING AS	Ordinary shares	8,995	0.17 %
R RYGA INVEST AS	Ordinary shares	8,981	0.17 %
CM Christian Maurangsnes Mæland 1979	Ordinary shares	8,696	0.16 %
TA Tor Andre Haveland 1970	Ordinary shares	8,500	0.16 %
L LEMBAS AS	Ordinary shares	8,192	0.15 %
PM Per Marius Vinsdal 1972	Ordinary shares	8,000	0.15 %
TE Tom Erik Van Oorschot 1962	Ordinary shares	7,938	0.15 %
C CANLUP AS	Ordinary shares	7,834	0.15 %
F FABE INVEST AS	Ordinary shares	7,834	0.15 %
J JEB AS	Ordinary shares	7,830	0.15 %
SA Shahram Ariafar 1975	Ordinary shares	7,175	0.13 %
OA Ole Andreas Heen 1972	Ordinary shares	7,137	0.13 %
SH Sven-Olai Høyland 1961	Ordinary shares	7,000	0.13 %
I IMMUVERA THERAPEUTICS AS	Ordinary shares	6,672	0.12 %
B BLOMGREN HOLDING AS	Ordinary shares	6,600	0.12 %
G GBOGH HOLDING AS	Ordinary shares	6,300	0.12 %
HA Hurni Andre	Ordinary shares	6,219	0.12 %
GH Gunilla Hagstedt	Ordinary shares	6,000	0.11 %
P PRODUKSJONSBOKSEN AS	Ordinary shares	5,876	0.11 %
FG Francesca Gatti 1979	Ordinary shares	5,875	0.11 %
OK Ohman Kristofer	Ordinary shares	5,500	0.1 %
JU John Ulriksen 1963	Ordinary shares	5,300	0.1 %
KA Kim Anders Øvrid 1976	Ordinary shares	5,000	0.09 %
V VOLL TECHNOLOGY AS	Ordinary shares	5,000	0.09 %
ØM Øystein Mikal Sunde 1957	Ordinary shares	5,000	0.09 %
NA Nils Arne Susort 1988	Ordinary shares	5,000	0.09 %
SM Snorre Moxnes 1967	Ordinary shares	5,000	0.09 %
H HANDSUP HOLDING AS	Ordinary shares	5,000	0.09 %
P PUSEHUSET HOLDING AS	Ordinary shares	4,650	0.09 %
S SOBISA AS	Ordinary shares	4,546	0.08 %
KA Kristian Afdal 1992	Ordinary shares	4,500	0.08 %
JE John-Arvid Eik 1983	Ordinary shares	4,350	0.08 %
SA Stefan Andersson 1982	Ordinary shares	4,302	0.08 %
LC Lise Catrine Gjelstad 1992	Ordinary shares	4,000	0.07 %
LN Livar Nedrebø 1968	Ordinary shares	4,000	0.07 %
ES Erik Stubø 1959	Ordinary shares	4,000	0.07 %
MS Martin Steen 1973	Ordinary shares	4,000	0.07 %
IV Iver Vattøy 1997	Ordinary shares	4,000	0.07 %
RM Richard M Edvinsen 1985	Ordinary shares	3,898	0.07 %
PR Per Roar Haug 1957	Ordinary shares	3,600	0.07 %
PA Per Alf Kjellin 1954	Ordinary shares	3,556	0.07 %
TA Trond Andreas Nordhus 1960	Ordinary shares	3,525	0.07 %
J JIREBE AS	Ordinary shares	3,500	0.06 %
U ULVUND INVEST AS	Ordinary shares	3,400	0.06 %
TL Terje Lingaas 1981	Ordinary shares	3,362	0.06 %
GN Gunhild Nersten 1991	Ordinary shares	3,175	0.06 %
LS Lisbeth Smith 1955	Ordinary shares	3,050	0.06 %
TB Toril Beate Nilsen 1966	Ordinary shares	3,000	0.06 %
TL Tove Lyngstad 1953	Ordinary shares	3,000	0.06 %
TR Tom Roger Nilsen 1978	Ordinary shares	2,950	0.05 %
JA Juridik Ab Holmquist	Ordinary shares	2,938	0.05 %
KH Kjersti Haugen 1930	Ordinary shares	2,937	0.05 %

Shares owned by the IMMUVERA THERAPEUTICS AS

Name	Share class	Total number of shares	Share
A ALVIRAL AS Under liquidation	Ordinary shares	297,000	99 %
I IMMUVERA THERAPEUTICS AS	Ordinary shares	6,672	0.12 %

Last update: Jun 2, 2025

Group structure

IMMUVERA THERAPEUTICS AS
Total operating income 2024: NOK 220,410
Operating profit 2024: NOK -5,909,101
Employees: 0

Financials

in NOK

Summary

Year	2024	2023	2022	2021
Total operating income	220,410	771,701	100,000	208,442
Annual Total Result	-5,918,424	-4,830,116	-6,094,266	-6,380,639
Total assets	20,556,270	13,409,838	7,310,721	1,913,532
Total liabilities	4,739,545	1,248,799	3,093,023	3,295,683
Total equity	15,816,725	12,161,039	4,217,698	-1,382,151

P&L

Year	2024	2023	2022	2021
Total operating income	220,410	771,701	100,000	208,442
Total operating costs	6,129,511	5,575,887	6,188,261	6,587,992
Operating result	-5,909,101	-4,804,185	-6,088,261	-6,379,550
Financial income/costs	-9,323	-25,931	-6,005	-1,089
Profit before tax	-5,918,424	-4,830,116	-6,094,266	-6,380,639
Total tax & extraordinary income/cost	0	0	0	0
Annual Total Result	-5,918,424	-4,830,116	-6,094,266	-6,380,639

Balance overview

Year	2024	2023	2022	2021
Total fixed assets	15,318,855	8,697,437	4,579,794	22,967
Total current assets	5,237,415	4,712,401	2,730,927	1,890,565
Total assets	20,556,270	13,409,838	7,310,721	1,913,532
Short term debt	1,838,909	1,248,799	2,846,408	3,295,683
Long term debt	2,900,636	0	246,615	0
Total liabilities	4,739,545	1,248,799	3,093,023	3,295,683
Contributed capital	15,816,725	12,194,180	4,217,698	4,998,488
Retained earnings	0	-33,141	0	-6,380,639
Total equity	15,816,725	12,161,039	4,217,698	-1,382,151
Total equity and liabilities	20,556,270	13,409,838	7,310,721	1,913,532

Classification

21st company classification

BETA

Scaleup

IMMUVERA THERAPEUTICS AS926 109 553

IMMUVERA THERAPEUTICS AS

Keywords

Organization

Ownership

Financials

Locations

Management

Management / administration

Board

Others

Top 10 individual shareholders

Ownership

Company shareholders

Shares owned by the IMMUVERA THERAPEUTICS AS

Group structure

Financials

Summary

P&L

Balance overview

Classification